Lee, Yeongun
Dho, So Hee
Lee, Jiyeon
Hwang, Ji-Hyun
Kim, Minjung
Choi, Won-Young
Lee, Jin-Young
Lee, Jongwon
Chang, Woochul http://orcid.org/0000-0001-7367-2586
Lee, Min Young
Choi, Jungmin http://orcid.org/0000-0002-8614-0973
Kim, Tae-You
Kim, Lark Kyun http://orcid.org/0000-0001-5983-4470
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2016M3A9B6026918, NRF-2016R1D1A1B01015292, NRF-2016M3C9A4921712, NRF-2016M3A9B6026918)
Yonsei University | Yonsei University College of Medicine (6-2020-0100)
Article History
Received: 13 July 2021
Revised: 12 November 2021
Accepted: 18 November 2021
First Online: 15 February 2022
Ethics approval and consent to participate
: The study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1608-040-784) and carried out in accordance with the ethical guidelines of the institution. Informed consent was obtained from all involved patients.
: All the patients involved in our study provided written consent for publication.
: Tae-You Kim is the CEO of IMBDx. The remaining authors declare no competing interests.